Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $7.8 billion.

  • Sanofi's Other Non-Current Liabilities fell 980.26% to $7.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 billion, marking a year-over-year decrease of 980.26%. This contributed to the annual value of $7.6 billion for FY2025, which is 1355.23% down from last year.
  • As of Q4 2025, Sanofi's Other Non-Current Liabilities stood at $7.8 billion, which was down 980.26% from $8.1 billion recorded in Q2 2025.
  • In the past 5 years, Sanofi's Other Non-Current Liabilities ranged from a high of $8.9 billion in Q2 2024 and a low of $1.3 billion during Q4 2022
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $7.9 billion (2025), whereas its average is $6.7 billion.
  • Per our database at Business Quant, Sanofi's Other Non-Current Liabilities plummeted by 2843.95% in 2021 and then skyrocketed by 55020.06% in 2023.
  • Quarter analysis of 5 years shows Sanofi's Other Non-Current Liabilities stood at $1.3 billion in 2021, then decreased by 1.64% to $1.3 billion in 2022, then surged by 550.2% to $8.2 billion in 2023, then rose by 5.77% to $8.7 billion in 2024, then decreased by 9.8% to $7.8 billion in 2025.
  • Its last three reported values are $7.8 billion in Q4 2025, $8.1 billion for Q2 2025, and $8.7 billion during Q4 2024.